Ensysce Biosciences logo

Ensysce Biosciences Share Price (NASDAQ: ENSC)

$2.09

-0.01

(-0.48%)

Last updated on

Check the interactive Ensysce Biosciences Stock chart to analyse performance

Ensysce Biosciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.06
    Today's High:$2.10

    Day's Volatility :2.14%

  • 52 Weeks Low:$1.62
    52 Weeks High:$14.67

    52 Weeks Volatility :88.96%

Ensysce Biosciences Stock Returns

PeriodEnsysce Biosciences IncIndex (Russel 2000)
3 Months
-5.86%
0.0%
6 Months
-60.79%
0.0%
1 Year
-61.86%
0.0%
3 Years
-99.86%
-4.7%

Ensysce Biosciences Inc Key Stats

Check Ensysce Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.1
Open
$2.1
Today's High
$2.1
Today's Low
$2.055
Market Capitalization
$6.2M
Today's Volume
$25.4K
52 Week High
$14.67
52 Week Low
$1.62
Revenue TTM
$7.4M
EBITDA
$-24.2M
Earnings Per Share (EPS)
$-3.51
Profit Margin
-88.78%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-289.96%

Stock Returns calculator for Ensysce Biosciences Stock including INR - Dollar returns

The Ensysce Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ensysce Biosciences investment value today

Current value as on today

₹43,423

Returns

₹56,577

(-56.58%)

Returns from Ensysce Biosciences Stock

₹61,861 (-61.86%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Ensysce Biosciences Stock

-46%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Ensysce Biosciences Stock from India on INDmoney has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ensysce Biosciences Inc

  • Name

    Holdings %

  • Murchinson Ltd.

    5.85%

  • Perceptive Advisors LLC

    3.62%

  • Adage Capital Partners Gp LLC

    3.12%

  • Sabby Management LLC

    1.96%

  • FNY Investment Advisers, LLC

    0.13%

  • Tower Research Capital LLC

    0.06%

Analyst Recommendation on Ensysce Biosciences Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Ensysce Biosciences(by analysts ranked 0 to 5 stars)

Ensysce Biosciences Share Price Target

What analysts predicted

Upside of 867.7%

Target:

$20.23

Current:

$2.09

Ensysce Biosciences share price target is $20.23, a slight Upside of 867.7% compared to current price of $2.09 as per analysts' prediction.

Ensysce Biosciences Stock Insights

  • Price Movement

    In the last 6 months, ENSC stock has moved down by -61.2%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.30M → 1.37M (in $), with an average increase of 2.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -3.56M → -1.73M (in $), with an average increase of 47.7% per quarter
  • ENSC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 134.6%
  • ENSC vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.5%
  • Price to Sales

    ForENSC every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Ensysce Biosciences Technicals Summary

Sell

Neutral

Buy

Ensysce Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ensysce Biosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Ensysce Biosciences Inc logo
0.0%
-60.79%
-61.86%
-99.86%
-100.0%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Ensysce Biosciences Inc

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat Opioid use disorder.Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.
Organization
Ensysce Biosciences
Employees
7
CEO
Dr. D. Lynn Kirkpatrick Ph.D.
Industry
Miscellaneous

Key Management of Ensysce Biosciences Inc

NameTitle
Dr. D. Lynn Kirkpatrick Ph.D.
President, CEO & Director
Mr. David C. Humphrey CPA
CFO, Secretary & Treasurer
Mr. Geoffrey Birkett
Chief Commercial Officer
Dr. Jeffrey Millard Ph.d.
Chief Operating Officer
Dr. William K. Schmidt Ph.D.
Chairman of Clinical Advisory Board & Chief Medical Officer
Dr. Linda Pestano Ph.D.
Chief Development Officer

Important FAQs about investing in ENSC Stock from India :

What is Ensysce Biosciences share price today?

Ensysce Biosciences share price today is $2.09 as on at the close of the market. Ensysce Biosciences share today touched a day high of $2.10 and a low of $2.06.

What is the 52 week high and 52 week low for Ensysce Biosciences share?

Ensysce Biosciences share touched a 52 week high of $14.67 and a 52 week low of $1.62. Ensysce Biosciences stock price today i.e. is closed at $2.09, lower by 85.75% versus the 52 week high.

How to invest in Ensysce Biosciences Stock (ENSC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ensysce Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ensysce Biosciences Shares that will get you 0.7177 shares as per Ensysce Biosciences share price of $2.09 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ensysce Biosciences Stock (ENSC) from India?

Indian investors can start investing in Ensysce Biosciences (ENSC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Ensysce Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Ensysce Biosciences share’s latest price of $2.09 as on August 30, 2025 at 1:29 am IST, you will get 4.7847 shares of Ensysce Biosciences. Learn more about fractional shares .

What are the returns that Ensysce Biosciences has given to Indian investors in the last 5 years?

Ensysce Biosciences stock has given -100.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?